1. Home
  2. TCRT vs CISS Comparison

TCRT vs CISS Comparison

Compare TCRT & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • CISS
  • Stock Information
  • Founded
  • TCRT 1998
  • CISS 2022
  • Country
  • TCRT United States
  • CISS Greece
  • Employees
  • TCRT N/A
  • CISS N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • CISS Marine Transportation
  • Sector
  • TCRT Health Care
  • CISS Consumer Discretionary
  • Exchange
  • TCRT Nasdaq
  • CISS Nasdaq
  • Market Cap
  • TCRT 3.8M
  • CISS 3.1M
  • IPO Year
  • TCRT N/A
  • CISS N/A
  • Fundamental
  • Price
  • TCRT $3.01
  • CISS $3.85
  • Analyst Decision
  • TCRT
  • CISS
  • Analyst Count
  • TCRT 0
  • CISS 0
  • Target Price
  • TCRT N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • TCRT 49.8K
  • CISS 30.6K
  • Earning Date
  • TCRT 05-19-2025
  • CISS 05-27-2025
  • Dividend Yield
  • TCRT N/A
  • CISS N/A
  • EPS Growth
  • TCRT N/A
  • CISS N/A
  • EPS
  • TCRT N/A
  • CISS N/A
  • Revenue
  • TCRT $10,000.00
  • CISS $42,296,101.00
  • Revenue This Year
  • TCRT $5,680,500.00
  • CISS N/A
  • Revenue Next Year
  • TCRT N/A
  • CISS N/A
  • P/E Ratio
  • TCRT N/A
  • CISS N/A
  • Revenue Growth
  • TCRT 100.00
  • CISS 47.17
  • 52 Week Low
  • TCRT $1.31
  • CISS $2.85
  • 52 Week High
  • TCRT $14.20
  • CISS $29.40
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 60.22
  • CISS 48.93
  • Support Level
  • TCRT $2.56
  • CISS $3.75
  • Resistance Level
  • TCRT $2.91
  • CISS $4.10
  • Average True Range (ATR)
  • TCRT 0.28
  • CISS 0.29
  • MACD
  • TCRT 0.02
  • CISS 0.08
  • Stochastic Oscillator
  • TCRT 100.00
  • CISS 67.78

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: